HERPAGOCIDE

HERPAGOCIDE is a pharmaceutical product designed to manage and treat conditions related to herpes simplex virus infections. It is formulated to alleviate symptoms and assist in the recovery process.

Indications

-Treatment of herpes simplex virus infections, including oral and genital herpes. -Relief from symptoms such as pain, itching, and burning.

Dosage

-Adults: Typically, the recommended dosage is 400 mg to 800 mg, administered 2 to 3 times daily, depending on the severity of the infection. -Children: Dosage for children should be adjusted based on body weight and specific medical guidance.

Contra-Indications

-Not recommended for individuals with hypersensitivity or allergy to the active ingredient or any component of the formulation. -Caution is advised in patients with renal impairment or other significant health conditions.

Special Precautions

-Use with caution in patients with a history of renal or hepatic impairment. -Regular monitoring is recommended during prolonged use. -Avoid use in pregnant or breastfeeding women unless deemed absolutely necessary by a healthcare provider.

Side Effects

-Common side effects may include nausea, headache, dizziness, and gastrointestinal disturbances. -Rare but serious side effects may include allergic reactions, severe skin rashes, and changes in kidney function.

Drug Interactions

-May interact with other antiviral medications, potentially affecting efficacy or increasing side effects. -Caution is advised when used in combination with drugs that affect kidney function or are metabolized by the liver.